Simplex Trading
ASND icon

Simplex Trading’s Ascendis Pharma A/S ASND Stock Holding History

Simplex Trading’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Buy
+8,275
New +$1.93M ﹤0.01% 1936
2025
Q1 		– Sell
-6,288
Closed -$898K – 8471
2024
Q4 		$865K Buy
6,288
+4,354
+225% +$572K ﹤0.01% 2989
2024
Q3 		$288K Buy
+1,934
New +$261K ﹤0.01% 4170
2024
Q1 		– Sell
-2,270
Closed -$324K – 8807
2023
Q4 		$285K Buy
+2,270
New +$226K ﹤0.01% 4278
2023
Q3 		– Sell
-5,364
Closed -$502K – 8613
2023
Q2 		$478K Buy
+5,364
New +$467K ﹤0.01% 3363
2023
Q1 		– Sell
-1,617
Closed -$185K – 8960
2022
Q4 		$197K Buy
+1,617
New +$188K ﹤0.01% 4246
2021
Q4 		– Sell
-432
Closed -$64.3K – 10424
2021
Q3 		$58K Hold
432
– – ﹤0.01% 7331
2021
Q2 		$56K Sell
432
-1,562
-78% -$208K ﹤0.01% 7499
2021
Q1 		$256K Sell
1,994
-2,264
-53% -$344K ﹤0.01% 4351
2020
Q4 		$710K Buy
4,258
+3,095
+266% +$512K ﹤0.01% 2984
2020
Q3 		$179K Sell
1,163
-844
-42% -$121K ﹤0.01% 4247
2020
Q2 		$296K Sell
2,007
-5,927
-75% -$814K ﹤0.01% 3542
2020
Q1 		$893K Buy
+7,934
New +$1.03M ﹤0.01% 1992
2019
Q4 		– Sell
-5,284
Closed -$587K – 7255
2019
Q3 		$508K Buy
5,284
+551
+12% +$61.5K ﹤0.01% 2606
2019
Q2 		$545K Buy
+4,733
New +$566K ﹤0.01% 2478
2019
Q1 		– Sell
-14,993
Closed -$1.31M – 7094
2018
Q4 		$939K Buy
+14,993
New +$942K ﹤0.01% 1688
2018
Q3 		– Sell
-2,864
Closed -$197K – 7366
2018
Q2 		$190K Buy
+2,864
New +$188K ﹤0.01% 3539

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Simplex Trading's ASND Position: Q2 2026 in Review

Simplex Trading opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 8,275 shares worth $2.21M. The stake represents ﹤0.01% of the portfolio and ranks #1936 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ASND as recently as Q4 2024.

Simplex Trading first reported a position in ASND in Q2 2018 and has held it in 17 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Simplex Trading held 8,275 shares of Ascendis Pharma A/S worth $2.21M as of Q2 2026.
  • Ascendis Pharma A/S was a new Simplex Trading position in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #1936 holding.
  • Simplex Trading first reported a position in Ascendis Pharma A/S in Q2 2018 and has held it in 17 quarters since.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.